CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Zenith® TX2® Low Profile TAA Endovascular Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01151020
NCT01151020N/ACompleted
CompareCT.gov

Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study

Cook Research Incorporated·interventional·Posted Jun 25, 2010·Updated Jan 22, 2021

In Brief

A clinical study evaluating Zenith® TX2® Low Profile TAA Endovascular Graft for Aortic Aneurysm and 2 related conditions. Completed, enrolled 110 participants across 33 sites in 6 countries.

Detailed Summary

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Penetrating Ulcer, Vascular Disease
CountriesGermany, Italy, Japan, Sweden, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 25, 2010
Enrollment StartMar 1, 2010
Primary CompletionJan 1, 2014
Study CompletionMay 11, 2018
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.0 years ago

Interventions

Zenith® TX2® Low Profile TAA Endovascular Graftdevice

Endovascular treatment of patients with aneurysms/ulcers of the descending thoracic aorta having morphology suitable for endovascular repair